Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
According to Johnson & Johnson's latest financial reports the company has $22.92 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $22.92 B | 2.9% |
2022-12-31 | $22.28 B | -29.51% |
2021-12-31 | $31.60 B | 25.5% |
2020-12-31 | $25.18 B | 30.58% |
2019-12-31 | $19.28 B | -2.03% |
2018-12-31 | $19.68 B | 7.6% |
2017-12-31 | $18.29 B | -56.34% |
2016-12-31 | $41.90 B | 9.2% |
2015-12-31 | $38.37 B | 15.98% |
2014-12-31 | $33.08 B | 13.3% |
2013-12-31 | $29.20 B | 38.49% |
2012-12-31 | $21.08 B | -34.63% |
2011-12-31 | $32.26 B | 16.64% |
2010-12-31 | $27.65 B | 42.38% |
2009-12-31 | $19.42 B | 51.65% |
2008-12-31 | $12.80 B | 37.51% |
2007-12-31 | $9.31 B | 128.09% |
2006-12-31 | $4.08 B | -74.69% |
2005-12-31 | $16.13 B | 25.26% |
2004-12-31 | $12.88 B | 35.29% |
2003-12-31 | $9.52 B | 27.4% |
2002-12-31 | $7.47 B | -6.23% |
2001-12-31 | $7.97 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.69 B | -57.72% | ๐จ๐ญ Switzerland |
Pfizer PFE | $12.69 B | -44.65% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $7.27 B | -68.25% | ๐บ๐ธ USA |
Medtronic MDT | $8.32 B | -63.71% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | $2.92 B | -87.23% | ๐บ๐ธ USA |
Sanofi SNY | $9.92 B | -56.70% | ๐ซ๐ท France |
Gilead Sciences GILD | $7.26 B | -68.32% | ๐บ๐ธ USA |
Stryker Corporation SYK | $3.05 B | -86.68% | ๐บ๐ธ USA |
Merck MRK | $7.09 B | -69.06% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $6.35 B | -72.28% | ๐ฌ๐ง UK |